Logo image
Gene expression analysis enriched
Journal article   Peer reviewed

Gene expression analysis enriched

Andres Kriete
Drug discovery today, v 9(21), pp 913-914
2004
PMID: 15501723

Abstract

Drug target development DNA microarrays Differential expression Histomorphometry Personalized Medicine
The use of DNA microarrays to identify genes that are upregulated or downregulated is a crucial component in the early phase of drug target development, optimization and clinical validation. It is well recognized that a significant change that is revealed by statistical methods, even if fitted to the experimental objectives, does not always unlock all the biologically significant changes that are related to disease or treatment. Novel approaches to enrich expression analysis by including information on pathways, biomedical literature or phenotype have therefore increased interest in this approach.

Metrics

7 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Logo image